Reproducible statistical computation on your empirical Excel master chart—from formula-backed sample size calculation to inferential hypothesis testing, 300-DPI figures, and complete Results chapters.
STAT-01
STAT-01
Formula-backed sample size and statistical power derivation dossier (Cochran, Daniel, Charan-Biswas, or two-group power equations) with 10% attrition adjustment and literature citation ready for IEC submission.
Inspect Deliverable Structure
Sample Power Derivation
Alpha = 0.05 (95% CI), Power = 80%, Effect Size = 0.50 → Base n = 128 (64/group); With 10% Attrition N = 143 subjects.
STAT-02
STAT-02
Raw Excel master chart cleaning, variable coding, missing-data audit, Shapiro-Wilk / Kolmogorov-Smirnov normality testing, descriptive tables (Mean ± SD, Median + IQR, n/%), and baseline demographic charts for up to 150 subjects and 20 variables.
Inspect Deliverable Structure
Sample Baseline Table
Age (Mean ± SD): Group A 42.4 ± 9.6 vs Group B 43.8 ± 10.1 (p = 0.41) | HbA1c Median (IQR): 7.6 (6.9–8.4)
STAT-03
STAT-03
Complete inferential biostatistics for up to 250 subjects, 20 variables, and 3 study objectives—covering parametric/non-parametric tests (t-test, ANOVA + Tukey, Mann-Whitney, Wilcoxon, Chi-square/Fisher's, correlation/regression, ROC/forest/box plots at 300 DPI) plus a written APA/Vancouver Results & Interpretation chapter.
Inspect Deliverable Structure
Sample Inferential Output
Unpaired t-test: t = 2.84, p = 0.005 | One-Way ANOVA with Tukey HSD: F = 6.12, p = 0.003 | Chi-Square: χ² = 7.45, p = 0.006
STAT-04
STAT-04
Comprehensive Drug Utilization Evaluation (DUE) and prescription audit for up to 300 encounters evaluated against WHO/INRUD core prescribing indicators, ATC/DDD classification, polypharmacy index, and essential medicines compliance.
Inspect Deliverable Structure
Sample WHO Indicator Audit
Avg drugs/encounter: 3.2 (WHO ref 1.6–1.8) | Generic prescribing: 54% | Antibiotic encounters: 38% | EML compliance: 84%